سعر اومانوز 25مجم 10 كبسولات 2022

Omanoz (atomoxetine) 25 mg capsules, pack of 10, by Sabaa (Hermes Lab Company, Egypt); a selective norepinephrine reuptake inhibitor for attention-deficit/hyperactivity disorder.

• Attention-deficit/hyperactivity disorderPopulation: Adults and pediatric patients 6 years and olderDailyMed (U.S. National Library of Medicine)

• Hypersensitivity to atomoxetine; use with or within 14 days of an MAOI; narrow angle glaucoma; pheochromocytoma or its history; severe cardiac or vascular disorders that would deteriorate with clinically important increases in blood pressure or heart rate.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Boxed warning: increased risk of suicidal ideation in pediatric patients 6 years and older; monitor closely for suicidal thoughts, clinical worsening or unusual behaviour changes, especially early in therapy and at dose changes.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Monoamine oxidase inhibitors (MAOIs)Contraindicated with or within 14 days of stopping an MAOI.DailyMed (U.S. National Library of Medicine)

• Published data are insufficient to establish a drug-associated risk of major birth defects, miscarriage or adverse outcomes; some animal studies showed adverse developmental outcomes. A national ADHD medication pregnancy registry exists.International label, same formulation · DailyMed (U.S. National Library of Medicine)
• No data on presence in human milk; atomoxetine is present in animal milk; weigh benefits of breastfeeding against potential adverse effects.International label, same formulation · DailyMed (U.S. National Library of Medicine)

English text not available for this section.